Skip to main content
Signal8

COMPASS Pathways plc (CMPS)

COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

COMPASS Pathways plc logo

COMPASS Pathways plc

NASDAQ:CMPSHealthcare
-5.09%$11.57
AH$11.63+0.52%vs close
Mkt Cap$1.6B
Float127.2M
O/S138.48M
Vol
$ Vol
RVOL
Inst Own65.6%
SI13.9%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$287.86M
Total Assets$210.35M
Free Cash Flow-$157.24M
Debt & Equity
Total Debt$20.93M
Total Equity-$52.85M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in CMPS's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$210.35M
Liabilities$263.2M
Accounts Receivable$15.39M
Accounts Payable$15.22M
Inventory$0
PP&E (Net)$3.42M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue$0$0$0$0$0$0$0$0
YoY Growth--------
Cost of Revenue$0$0$0$0$0$113K$63K$0
Gross Profit$0$0$0$0$0-$113K-$63K$0
Gross Margin--------
Research and Development$118.44M$119.04M$87.52M$65.05M$44.03M$23.37M$12.56M$8.92M
Selling, General, and Administrative$60.6M$59.17M$49.4M$45.35M$39.19M$28.03M$8.62M$3.59M
Other$0$0$0$0$0$287K$0$0
Total Operating Expenses$179.04M$178.21M$136.92M$110.4M$83.22M$51.68M$21.18M$12.5M
Operating Income (EBIT)-$179.04M-$178.21M-$136.92M-$110.4M-$83.22M-$51.79M-$21.18M-$12.5M
Operating Margin--------
Interest Expense$4.52M$4.48M$2.2M$0$0$0$0$0
Interest Income$7.18M$8.27M$4.62M$0$0$0$0$0
Other Income (Expense)-$111.3M$24.68M$19.23M$19.31M$11.68M-$13.26M$1.58M-$716K
Income Before Tax (EBT)-$290.33M-$153.53M-$117.68M-$91.1M-$71.54M-$65.05M-$19.6M-$13.22M
Income Tax Expense-$2.47M$1.59M$780K$408K$199K-$4.25M$15K$0
Net Income-$287.86M-$155.12M-$118.46M-$91.5M-$71.74M-$60.8M-$19.61M-$13.22M
Net Income Margin--------
Supplementary Data
EPS-3.08-2.30-2.32-2.16-1.79-1.68-0.90-2.35
Diluted EPS-3.08-2.30-2.32-2.16-1.79-1.68-0.90-2.35
Weighted Average OS93.50M67.48M51.03M42.44M40.00M35.93M21.72M5.62M
EBITDA-$285.6M-$148.82M-$115.24M-$90.77M-$71.37M-$64.94M-$22.26M-$10.52M
EBITDA Margin--------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Assets
Current Assets
Cash and Cash Equivalents$149.61M$165.08M$220.2M$143.21M$273.24M$190.33M$24.97M$22.91M
Short-Term Investments$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$149.61M$165.08M$220.2M$143.21M$273.24M$190.33M$24.97M$22.91M
Accounts Receivable$15.39M$21.82M$28.93M$15.62M$11.22M$0$0$2.14M
Inventory$0$0$0$0$0$0$0$943K
Other Current Assets$5.96M$2.58M$2.33M$1.22M$2.31M$8.92M$6.99M$288K
Total Current Assets$191.49M$201.29M$261.3M$191.65M$295.3M$202.4M$32.17M$26.28M
Long-Term Assets
Property, Plant & Equipment Net$3.42M$2.19M$4.73M$2.62M$4.09M$245K$218K$108K
Goodwill$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0
Long-Term Investments$10.95M$469K$469K$469K$525K$529K$0$0
Deferred Tax Assets$3.75M$3.77M$3.34M$2.22M$766K$0$0$0
Other Long-Term Assets$734K$5.94M$6.16M$327K$213K$278K$0$0
Total Long-Term Assets$18.86M$12.38M$14.69M$5.64M$5.6M$1.05M$218K$108K
Other Assets$0$0$0$0$0$0$0$0
Total Assets$210.35M$213.67M$275.99M$197.29M$300.9M$203.46M$32.39M$26.39M
Liabilities
Current Liabilities
Accounts Payable$15.22M$12.28M$5.89M$4.76M$2.56M$2.75M$1.32M$694K
Short-Term Debt$19.63M$5.51M$0$0$0$0$21.09M$0
Current Income Tax Payable$0$0$13K$167K$593K$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0
Other Current Liabilities$212.94M$9.24M$8.09M$6.19M$5.29M$656K$52K$0
Total Current Liabilities$247.79M$34.02M$19.6M$15.6M$15.11M$6.89M$23.87M$1.85M
Long-Term Liabilities
Long-Term Debt$1.29M$24.65M$28.76M$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$14.11M$0$0$0$0$0$0$38.91M
Total Long-Term Liabilities$15.4M$24.95M$30.64M$418K$1.38M$0$0$38.91M
Other Liabilities$0$0$0$0$0$0$0$0
Total Liabilities$263.2M$58.97M$50.24M$16.01M$16.49M$6.89M$23.87M$40.75M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$38.91M$38.91M
Common Stock$973K$702K$635K$440K$435K$367K$111K$122K
Retained Earnings-$822.59M-$534.73M-$379.61M-$261.15M-$169.64M-$97.9M-$37.56M-$17.95M
Comprehensive Income & Other-$14.79M-$16.19M-$16.93M-$16.87M$8.84M$14.61M-$98K-$435K
Other Stockholders' Equity$768.77M$688.73M$604.72M$441.99M$453.62M$294.09M$45.97M$3.46M
Total Equity-$52.85M$154.69M$225.74M$181.28M$284.41M$196.56M$8.52M-$14.37M
Minority Interest$0$0$0$0$0$0$0$0
Total Liabilities and Equity$210.35M$213.67M$275.99M$197.29M$300.9M$203.46M$32.39M$26.39M
Supplementary Data
Total Debt$20.93M$32.19M$33.05M$1.93M$3.61M$0$21.09M$0
Net Debt-$128.68M-$132.89M-$187.15M-$141.28M-$269.63M-$190.33M-$3.88M-$22.91M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Operating Activities
Net Income-$287.86M-$155.12M-$118.46M-$91.5M-$71.74M-$60.33M-$19.61M-$13.22M
Depreciation & Amortization$216K$233K$242K$330K$175K$112K$63K$22K
Deferred Income Tax$0$0$0$0$22K-$221K$0$0
Stock-Based Compensation$13.59M$19.52M$17.28M$13.12M$8.64M$17.98M$3.25M$1.42M
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0
  Accounts Payable$2.03M$6.59M$864K$2.5M-$163K$1.3M$580K-$12K
  Other Working Capital-$16.32M$5.13M$2.62M-$33.16M-$6.47M-$2.21M-$3.24M-$692K
Total Working Capital Change-$14.28M$11.72M$3.48M-$30.67M-$6.64M-$912K-$2.66M-$704K
Other Non-Cash Items$131.1M$4.46M$86K$3.27M$1.8M$1.99M$1.14M$2.68M
Net Cash from Operating-$157.24M-$119.19M-$97.38M-$105.45M-$67.75M-$41.38M-$17.81M-$9.8M
Investing Activities
Capital Expenditures$0$0-$66K-$596K-$334K-$131K-$165K-$130K
Acquisitions$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0-$497K$0$0
Sales of Investments$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$2K$0$0$0$0$0
Net Cash from Investing$0$0-$64K-$596K-$334K-$628K-$165K-$130K
Financing Activities
Debt Repaid---$29.59M-----
Common Stock Issuance$141.04M$26.22M$144.94M$440K$154.79M$132.82M$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0
Other Financing Activities-$329K$37.6M-$690K$600K$1.85M$16K-$55K$0
Net Cash from Financing$140.71M$63.82M$173.83M$1.04M$156.65M$194.16M$18.38M$32.96M
Forex Effect$1.04M$194K$867K-$24.96M-$5.58M$13.22M$1.68M-$1.17M
Net Change in Cash-$15.48M-$55.17M$77.26M-$129.97M$82.99M$165.37M$2.08M$21.86M
Supplementary Data
Operating Cash Flow-$157.24M-$119.19M-$97.38M-$105.45M-$67.75M-$41.38M-$17.81M-$9.8M
Capital Expenditure$0$0-$66K-$596K-$334K-$131K-$165K-$130K
Free Cash Flow-$157.24M-$119.19M-$97.44M-$106.05M-$68.08M-$41.51M-$17.98M-$9.93M
Cash at Beginning$165.47M$220.64M$143.38M$273.35M$190.36M$24.98M$22.91M$1.04M
Cash at End$149.99M$165.47M$220.64M$143.38M$273.35M$190.36M$24.98M$22.91M